Vaccine |
BNT162b2, mRNA-1273, AZD1222, Ad26.COV2.S |
Fevers, chills,aches, allergic reaction, neurologic complications, fatigue, headache.200
|
BNT162b2, mRNA-1273 |
Injection site pain, fatigue, headache, and myalgia, second dose for both vaccines, particularly for systemic reactions, chills, fever, and joint pain.201,202
|
BNT162b2, mRNA-1273 |
Anaphylaxis.203
|
BBIBP-CorV |
Fever, injection site pain, tenderness, redness, headache, fatigue, nausea, diarrhea, cough, allergy, muscle pain, abdominal pain,lethargy, back pain.204
|
CoronoVac |
Pain, redness, swelling, injection site pain, pruritus, cough, fatigue, diarrhea, back pain, hypersensitivity, muscle pain, decreased appetite.205
|
BBV152 |
Headache, fatigue, nausea, vomiting, fever, injection site pain.206
|
Convalescent Plasma |
ClinicalTrials.gov number, NCT04373460
|
Pneumonitis, headache, hypertension, non-cardiac chest pain, infusion related reaction.86
|
ClinicalTrials.gov number, NCT04338360. |
Mortality, circulatory overload, acute lung injury, severe allergic transfusion reaction.207
|
Neutralizing antibodies |
Bamlanivimab monotherapy or combination therapy of bamlanivimab and etesevimab |
Chills, diarrhea, dizziness, headache, nasal congestion, nausea, pruritus, pyrexia, rash, syncope, vomiting.208
|
Casirivimab and imdevimab |
Vomiting, nausea, abdominal pain, pruritus, urticaria, chills, flushing.99
|
T cell/NK cell based therapeutics |
NK cells and/or memory T cell infusion |
Infusion reactions, side effects related to frozen products, graft-versus-host disease.209
|